BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16807238)

  • 1. Osteopontin induction of hyaluronan synthase 2 expression promotes breast cancer malignancy.
    Cook AC; Chambers AF; Turley EA; Tuck AB
    J Biol Chem; 2006 Aug; 281(34):24381-9. PubMed ID: 16807238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
    Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
    Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells.
    Li Y; Li L; Brown TJ; Heldin P
    Int J Cancer; 2007 Jun; 120(12):2557-67. PubMed ID: 17315194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
    Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.
    Li P; Xiang T; Li H; Li Q; Yang B; Huang J; Zhang X; Shi Y; Tan J; Ren G
    Int J Clin Exp Pathol; 2015; 8(10):12101-14. PubMed ID: 26722395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation.
    Itano N; Sawai T; Atsumi F; Miyaishi O; Taniguchi S; Kannagi R; Hamaguchi M; Kimata K
    J Biol Chem; 2004 Apr; 279(18):18679-87. PubMed ID: 14724275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manipulation of hyaluronan synthase expression in prostate adenocarcinoma cells alters pericellular matrix retention and adhesion to bone marrow endothelial cells.
    Simpson MA; Wilson CM; Furcht LT; Spicer AP; Oegema TR; McCarthy JB
    J Biol Chem; 2002 Mar; 277(12):10050-7. PubMed ID: 11790779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural antisense mRNAs to hyaluronan synthase 2 inhibit hyaluronan biosynthesis and cell proliferation.
    Chao H; Spicer AP
    J Biol Chem; 2005 Jul; 280(30):27513-22. PubMed ID: 15843373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense-mediated suppression of hyaluronan synthase 2 inhibits the tumorigenesis and progression of breast cancer.
    Udabage L; Brownlee GR; Waltham M; Blick T; Walker EC; Heldin P; Nilsson SK; Thompson EW; Brown TJ
    Cancer Res; 2005 Jul; 65(14):6139-50. PubMed ID: 16024615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell.
    Michael DR; Phillips AO; Krupa A; Martin J; Redman JE; Altaher A; Neville RD; Webber J; Kim MY; Bowen T
    J Biol Chem; 2011 Jun; 286(22):19523-32. PubMed ID: 21357421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
    Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
    Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression.
    Cook AC; Tuck AB; McCarthy S; Turner JG; Irby RB; Bloom GC; Yeatman TJ; Chambers AF
    Mol Carcinog; 2005 Aug; 43(4):225-36. PubMed ID: 15864800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1).
    Bernert B; Porsch H; Heldin P
    J Biol Chem; 2011 Dec; 286(49):42349-42359. PubMed ID: 22016393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.
    Simpson MA
    Am J Pathol; 2006 Jul; 169(1):247-57. PubMed ID: 16816377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism.
    Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D
    Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts.
    Kretschmer I; Freudenberger T; Twarock S; Yamaguchi Y; Grandoch M; Fischer JW
    J Biol Chem; 2016 Feb; 291(8):4091-106. PubMed ID: 26699196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
    Kosaki R; Watanabe K; Yamaguchi Y
    Cancer Res; 1999 Mar; 59(5):1141-5. PubMed ID: 10070975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes.
    Rilla K; Lammi MJ; Sironen R; Törrönen K; Luukkonen M; Hascall VC; Midura RJ; Hyttinen M; Pelkonen J; Tammi M; Tammi R
    J Cell Sci; 2002 Sep; 115(Pt 18):3633-43. PubMed ID: 12186949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Osteopontin in tumor metastasis.
    Wai PY; Kuo PC
    J Surg Res; 2004 Oct; 121(2):228-41. PubMed ID: 15501463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
    El-Tanani MK; Jin D; Campbell FC; Johnston PG
    Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.